Clik here to view.
Clik here to view.
SPARC receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA
SPARC receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA : Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the U.S. Food and Drug Administration (FDA) has...
View ArticleSun Pharmaceuticals-Update
This article has been authored by Ms. Sarabjit Kour Nangra Sun Pharmaceuticals-Update: US Food and Drug Administration (FDA) have approved SPARC’s new drug application (NDA) for ELEPSIA XR...
View ArticleSun Pharmaceuticals & Ranbaxy Labs Merger approved
This article has been authored by Ms.Ms. Sarabjit Kour Nangra Sun Pharmaceuticals & Ranbaxy Labs Merger approved: Sun Pharmaceutical Industries has informed that it has received all the requisite...
View ArticleSun Pharmaceuticals – Update
Sun Pharmaceuticals- Update: Sun Pharma’s Active Pharma Ingredients plant in Ahmednagar was audited by the American drug regulator USFDA last month. It has been reported there have been some minor...
View ArticleSun Pharma announces US FDA approval for XiminoTM
This article has been authored by Ms. Sarabjit Kour Nangra Sun Pharma announces US FDA approval for XiminoTM :Sun Pharmaceutical today announced that the U.S. Food and Drug Administration (FDA) has...
View ArticleSun Pharmaceuticals : Absorica patent litigation settlement
This article has been authored by Ms. Sarabjit Kour Nangra. Sun Pharmaceuticals announces Absorica patent litigation settlement: Sun Pharmaceutical Industries today announced that Ranbaxy...
View ArticleSun Pharma – Update
Sun Pharma has received a warning letter from the USFDA for manufacturing lapses at its facility in Halol. The Halol facility was inspected by the USFDA in September 2014, following which the...
View Article
